miR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type.
miR-200c 过表达与 EGFR 野生型非小细胞肺癌患者 EGFR-TKI 的疗效提高相关
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.2302
Li Jiayu, Li Xuefei, Ren Shengxiang, Chen Xiaoxia, Zhang Yishi, Zhou Fei, Zhao Mingchuan, Zhao Chao, Chen Xiu, Cheng Ningning, Zhao Yinmin, Zhou Caicun, Hirsch Fred R